JP2023513731A5 - - Google Patents
Info
- Publication number
- JP2023513731A5 JP2023513731A5 JP2022548818A JP2022548818A JP2023513731A5 JP 2023513731 A5 JP2023513731 A5 JP 2023513731A5 JP 2022548818 A JP2022548818 A JP 2022548818A JP 2022548818 A JP2022548818 A JP 2022548818A JP 2023513731 A5 JP2023513731 A5 JP 2023513731A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062977316P | 2020-02-16 | 2020-02-16 | |
| US62/977,316 | 2020-02-16 | ||
| PCT/US2021/018137 WO2021163676A1 (en) | 2020-02-16 | 2021-02-16 | Methods of preparing chiral benzodiazepinone derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023513731A JP2023513731A (ja) | 2023-04-03 |
| JP2023513731A5 true JP2023513731A5 (https=) | 2024-02-22 |
Family
ID=77291712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548818A Pending JP2023513731A (ja) | 2020-02-16 | 2021-02-16 | キラルベンゾジアゼピノン誘導体の調製方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12503449B2 (https=) |
| EP (1) | EP4107148A4 (https=) |
| JP (1) | JP2023513731A (https=) |
| KR (1) | KR20220143094A (https=) |
| CN (1) | CN115103836A (https=) |
| AU (1) | AU2021218456A1 (https=) |
| BR (1) | BR112022016249A2 (https=) |
| CA (1) | CA3171651A1 (https=) |
| IL (1) | IL295572A (https=) |
| MX (1) | MX2022010079A (https=) |
| WO (1) | WO2021163676A1 (https=) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0253571B1 (en) * | 1986-07-14 | 1989-08-23 | Merck & Co. Inc. | Process for resolution and race mization of amines with acidic alpha-hydrogens |
| NL9000386A (nl) * | 1990-02-16 | 1991-09-16 | Stamicarbon | Werkwijze voor de bereiding van optisch aktief aminozuuramide. |
| JPH0751555B2 (ja) | 1992-04-15 | 1995-06-05 | キヤノン株式会社 | ジイモニウム塩化合物 |
| BRPI0520554A2 (pt) * | 2005-09-19 | 2009-06-13 | Arrow Therapeutics Ltd | uso de uma benzodiazepina ou um sal farmaceuticamente aceitável do mesmo, método para tratar ou prevenir uma infecção por hcv em um paciente, derivado de benzodiazepina ou um sal famaceuticamente aceitável do mesmo, e, composição farmacêutica |
| WO2010073253A1 (en) | 2008-12-22 | 2010-07-01 | Natco Pharma Limited | Method for preparing an optically active frovatriptan |
| WO2013148554A1 (en) * | 2012-03-30 | 2013-10-03 | Merck Sharp & Dohme Corp. | Process for preparing fluoroleucine alkyl esters |
| CN105308030A (zh) * | 2012-09-21 | 2016-02-03 | 百时美施贵宝公司 | 烷基、氟烷基-1,4-苯并二氮杂*酮化合物 |
| EP2897942B1 (en) | 2012-09-21 | 2016-08-31 | Bristol-Myers Squibb Company | Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds as notch inhibitors |
| WO2014047392A1 (en) | 2012-09-21 | 2014-03-27 | Bristol-Myers Squibb Company | Fluoroalkyl-1,4-benzodiazepinone compounds |
| TWI614238B (zh) * | 2012-09-21 | 2018-02-11 | 必治妥美雅史谷比公司 | 雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥 |
| JP6687596B2 (ja) | 2015-02-17 | 2020-04-22 | アモーレパシフィック コーポレーションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ | Ｎ−［４−（１−アミノエチル）−フェニル］−スルホンアミド誘導体のキラル分割方法 |
| CN105439939B (zh) | 2015-11-12 | 2018-12-04 | 四川恒康科技发展有限公司 | 一种(S)-N-Boc-3-羟基哌啶的合成方法 |
-
2021
- 2021-02-16 CN CN202180014113.5A patent/CN115103836A/zh active Pending
- 2021-02-16 JP JP2022548818A patent/JP2023513731A/ja active Pending
- 2021-02-16 MX MX2022010079A patent/MX2022010079A/es unknown
- 2021-02-16 CA CA3171651A patent/CA3171651A1/en active Pending
- 2021-02-16 WO PCT/US2021/018137 patent/WO2021163676A1/en not_active Ceased
- 2021-02-16 IL IL295572A patent/IL295572A/en unknown
- 2021-02-16 BR BR112022016249A patent/BR112022016249A2/pt unknown
- 2021-02-16 KR KR1020227032186A patent/KR20220143094A/ko active Pending
- 2021-02-16 EP EP21753186.2A patent/EP4107148A4/en active Pending
- 2021-02-16 US US17/799,680 patent/US12503449B2/en active Active
- 2021-02-16 AU AU2021218456A patent/AU2021218456A1/en active Pending
-
2025
- 2025-07-24 US US19/279,615 patent/US20250346565A1/en active Pending